Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement-Reference-Cited by-同舟云学术

Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement

Published:2007-11 Issue:11 Volume:31 Page:1585-1587
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Knipp Sabine,Gattermann Norbert,Schapira Marc,Käferstein Herbert,Germing Ulrich

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference10 articles.

1. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide;Soignet;N Engl J Med,1998

2. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients;Niu;Blood,1999

3. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins;Chen;Blood,1996

4. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients;Shen;Blood,1997

5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells;Chen;Blood,1997

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications;Cell Death Discovery;2023-07-27

2. Children's Oncology Group's 2023 blueprint for research: Behavioral science;Pediatric Blood & Cancer;2023-07-10

3. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions;Frontiers in Oncology;2023-01-18

4. Childhood Acute Promyelocytic Leukemia;Reference Module in Biomedical Sciences;2023

5. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol;British Journal of Clinical Pharmacology;2021-03-20